Advertisement

Allylamine Cardiovascular Toxicity: Modulation of the Monoamine Oxidase System and Biotransformation to Acrolein

  • P. J. Boor
  • T. J. Nelson
  • M. T. Moslen
  • P. Chieco
  • A. E. Ahmed
  • E. S. Reynolds
Part of the Proceedings in Life Sciences book series (LIFE SCIENCES)

Abstract

Allylamine (3-aminopropene) is an aliphatic amine which is used in the production of drugs, antiseptics, and plastics. Many previous experimental studies have demonstrated the potent toxicity of allylamine toward the myocardium (Boor et al. 1979), coronary arteries (Lalich et al. 1972; Saito et al. 1977), aorta (Lalich 1969), and large arteries (Lowman et al. 1966, 1969).

Keywords

Monoamine Oxidase Aliphatic Amine Amine Oxidase Allyl Alcohol Diamine Oxidase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alarcon RA (1968) Fluorometric determination of acrolein and related compounds with m-aminophenol. Anal Chem 40: 1704–1708PubMedCrossRefGoogle Scholar
  2. Boor PJ, Nelson TJ (1979) Allylamine cardiotoxicity and cardiac MAO: Modulation by MAO inhibitors. Toxicol Appl Pharmacol 48:A94Google Scholar
  3. Boor PJ, Moslen MT, Reynolds ES (1979) Allylamine cardiotoxicity: I. Sequence of pathologic events. Toxicol Appl Pharmacol 50: 581–592PubMedCrossRefGoogle Scholar
  4. Boor PJ, Nelson TJ, Chieco P (1980) Allylamine cardiotoxicity: II. Histopathology and histochemistry. Am J Pathol 100: 111–136Google Scholar
  5. Buffoni F (1980) Some contributions to the problem of amine oxidase. Pharmacol Res Commun 12: 101–114PubMedCrossRefGoogle Scholar
  6. Izard C, Libermann C (1978) Acrolein. Mutat Res 47: 115–138Google Scholar
  7. Jain M, Sands F, von Korff RW (1973) Monoamine oxidase activity measurement using radio-active substrates. Anal Biochem 52: 542–554PubMedCrossRefGoogle Scholar
  8. Lalich JJ (1969) Coronary artery hyalinosis in rats fed allylamine. Exp Mol Pathol 10: 14–26PubMedCrossRefGoogle Scholar
  9. Lalich JJ, Allen JR, Paik WCW (1972) Myocardial fibrosis and smooth muscle cell hyperplasia in coronary arteries of allylamine-fed rats. Am J Pathol 66: 225–240PubMedGoogle Scholar
  10. Lewinsohn R, Böhm K-H, Glover V, Sandler M (1978) A benzylamine oxidase distinct from monoamine oxidase B-widespread distribution in man and rat. Biochem Pharmacol 27: 1857–1863PubMedCrossRefGoogle Scholar
  11. Lowman RM, Hipona FA, Vidone RA (1966) The experimental production of unilateral renal artery injury and hypertension. I. The arteriography of allylamine-induced renal vascular lesions in the dog. Radiology 86: 1003–1009PubMedGoogle Scholar
  12. Lowman RM, Solitaire GB, McAllister WB (1969) Experimental production of intracranial vascular lesions: Allylamine-induced vascular lesions of the brain and intracranial infarction. Acta Radiol Diagn 9: 383–398Google Scholar
  13. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275PubMedGoogle Scholar
  14. Müller E (1966) Histochemical studies on the experimental heart infarction in the rat. Naunyn-Schmiedebergs Arch Pharmakol Exp Pathol 254: 430–447Google Scholar
  15. Rando R, Eigner A (1977) The pseudoirreversible inhibition of monoamine oxidase by allylamine. Mol Pharmacol 13: 1005–1013PubMedGoogle Scholar
  16. Saito D, Haraoka S, Hirano K, Ueda M, Fujimoto T (1977) Effect of diltiazem on coronary blood flow of the heart with experimental coronary sclerosis and on regional myocardial blood flow of the heart with acute myocardial ischemia. Arzneimittelforsch/Drug Res 27 (II): Nr. 9: 1669–1671Google Scholar
  17. Serafini-Cessi F (1972) Conversion of allyl alcohol into acrolein by rat liver. Biochem J 128: 1103–1107PubMedGoogle Scholar
  18. Suzuki O, Noguchi E, Yagi K (1976) A simple micro-determination of type B monoamine oxidase. Biochem Pharmacol 25: 2759–2760PubMedCrossRefGoogle Scholar
  19. Valiev AG (1968) Influence excreted by some aliphatic amines on the monoamine oxidase activity in rats. Farmakol Tosikol (Moscow) 31: 238–240Google Scholar
  20. Valiev AG (1974) Metabolism of biogenic amines during alkylamine poisoning. Vopr Biokhim Immunol Chel Zhivotnovud 33–37. ( Kindly translated by DePorte MP, NIH Library )Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1981

Authors and Affiliations

  • P. J. Boor
  • T. J. Nelson
  • M. T. Moslen
  • P. Chieco
  • A. E. Ahmed
  • E. S. Reynolds
    • 1
  1. 1.Department of Pathology, Chemical Pathology DivisionUniversity of Texas Medical BranchGalvestonUSA

Personalised recommendations